CKD

This study tests whether a new drug, vicadrostat, works differently than the older drug spironolactone when both are taken with empagliflozin. About 100 adults with chronic kidney disease and heart disease or heart failure will take one of the two combinations for 26 weeks. Resea…

This study tests a drug called veverimer in 150 adults with moderate-to-severe chronic kidney disease (CKD) and a condition called metabolic acidosis, where too much acid builds up in the blood. The goal is to see if the drug can raise blood bicarbonate levels and improve physica…

This study tests a new treatment called AdiaVita, made from umbilical cord stem cells and glutathione, in 100 adults with chronic kidney disease (stages 2-4). Participants receive monthly IV infusions for 3 months and use a skin spray at home. The goal is to see if the treatment …

This study looks at whether a drug called Xiqing, which removes waste from the blood, works better when combined with probiotics (good bacteria) in people with chronic kidney disease (CKD). The goal is to see if this combination can slow kidney damage and delay the need for dialy…

This study looks at whether using a salt substitute instead of regular salt can help protect kidney function in people who have had surgery for a kidney tumor. About 200 adults will be randomly assigned to use either a salt substitute or regular salt for one year. Researchers wil…

This study looks at how calcium and phosphorus from food affect people with advanced chronic kidney disease (stages 4 and 5). Researchers will compare two ways of tracking what patients eat—taking photos of meals versus writing down everything—to see which works better. The goal …